The Effect of Topical Almond Oil vs. Topical Retinol on The Appearance of Facial Wrinkles
NCT ID: NCT05011461
Last Updated: 2023-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2021-05-17
2022-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effects of Topical Almond Oil and Tretinoin on Facial Wrinkles
NCT06571721
The Effects of Almond on Facial Skin Collagen and Wrinkles
NCT06074276
Prospective Study of Topical Adapinoid Versus Topical Retinol
NCT05778760
Comparison of the Cosmetic Effects of Bakuchiol and Retinol
NCT03112863
A Study to Evaluate and Compare the Efficacy of Two Facial Creams on Moderately to Severely Photodamaged Skin
NCT06852742
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Almond Oil
Almond Oil Pressed Cold
Almond Oil
Almond Oil Pressed Cold
Topical Retinol
Retinol Lotion 0.5%
Almond Oil
Almond Oil Pressed Cold
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Almond Oil
Almond Oil Pressed Cold
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Smoking is an independent risk factor and serves as a confounder for the development of facial wrinkles and photoaging \[14\]. Therefore, current smokers, those that have smoked within the past year, and former smokers with greater than a 20-pack year history of smoking will be excluded.
* Those with an autoimmune photosensitive condition or a known genetic condition with a deficiency in collagen production (such as Ehlers-Danlos syndromes) will be excluded as this can be a confounder for facial wrinkles.
* Those who have undergone any cosmetic procedures to the face in the 4 months prior to enrollment in the opinion of the investigator. People that have undergone deeper chemical peels (TCA based peels) within 1 year prior to enrollment will also not be eligible.
* Individuals who are unwilling to discontinue vitamin E food sources during the washout and intervention. This includes
* Vitamin E containing supplements.
* Sunflower seeds or sunflower oil.
* All nuts.
* Individual who are unwilling to discontinue topical cosmetic products during the duration of the study or unwilling to undergo a 2-week washout of topicals that are known to modulate collagen and pigment:
* Retinoids such as tretinoin, adapalene, retinol, except as provided by the study.
* Antioxidant ingredients such as vitamin C or vitamin E.
* Pigment reducing agents such as hydroquinone, a retinoid, azelaic acid, kojic acid, pomegranate seed oil, and other similar agents per the discretion of the investigator, except for the retinol that is provided in this study.
* Topicals that contain a nut oil or nut extract as part of their ingredient list.
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, Davis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Raja Sivamani, MD
Associate Professor of Clinical Dermatology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Raja Sivamani, M.D.
Role: PRINCIPAL_INVESTIGATOR
UC Davis Dermatology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UC Davis Department of Dermatology, Clinical Trials Unit
Sacramento, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1666459
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.